Husayan, Henderson C.
HRN: 07-07-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2022
CEFUROXIME 750MG (VIAL)
10/16/2022
10/22/2022
IVT
750mg
Q8hrs
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes